Effectiveness of the influenza vaccine for preventing laboratory-confirmed influenza infections in outpatient immunocompromised adults, 2017

Effectiveness of the influenza vaccine for preventing laboratory-confirmed influenza infections in outpatient immunocompromised adults, 2017–2018

Published:2024-06-19 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Hughes Kramer Kailey¹^ORCID,Zimmerman Richard K.¹,Haggerty Catherine L.¹,Balasubramani G. K.¹,Nowalk Mary Patricia¹,Martin Emily T.²,Gaglani Manjusha³,Phillips C. Hallie⁴,Belongia Edward⁵,Chung Jessie⁶,Silveira Fernanda P.¹

Affiliation:

1. Medicine, Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, USA

2. Epidemiology, University of Michigan, Ann Arbor, MI, USA

3. Pediatrics, Pediatric Infectious Diseases, Baylor Scott and White, Austin, TX, USA

4. Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA

5. Center for Clin Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, WI, USA

6. Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA

Funder

that there is no funding

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2354013

Reference36 articles.

1. CDC. Burden of Influenza. Centers for Disease Control and Prevention; 2011 June 11 [Accessed 2021 July 19]. https://www.cdc.gov/flu/about/burden/index.html.

2. Hospitalization following outpatient medical care for influenza: US influenza vaccine effectiveness network, 2011-12-2015-16

3. Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States

4. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season

5. Influenza vaccination in solid-organ transplant recipients